Meeting
2022 ASCO Genitourinary Cancers Symposium
Body fat composition as biomarker for clinical outcomes and treatment tolerance in high-risk prostate cancer.
Authors
Anurag Saraf
Harvard Radiation Oncology Program, Boston, MA
Anurag Saraf , Zhongyi Zhang , Jack Qian , Christian V Gurthier , Jakob Weiss , Vinayak Muralidhar , Subha Perni , Danielle Sara Bitterman , Benjamin Harris Kann , Anthony Victor D'Amico , Hugo Aerts , Raymond H. Mak , Paul L. Nguyen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 159)
DOI
10.1200/JCO.2022.40.6_suppl.159
Abstract #
159
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes in men with unfavorable intermediate-risk and high-risk prostate cancer treated with prostate-only versus whole pelvic radiation therapy.
First Author: Neal Andruska
Poster
2018 Genitourinary Cancers Symposium
Three-month post-treatment PSA as a biomarker of treatment response in intermediate or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
First Author: Bryant Alex
Poster
2017 Genitourinary Cancers Symposium
Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
First Author: Michael Wang
Poster
2024 ASCO Breakthrough
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer: A multicenter study.
First Author: Fumihiko Urabe